BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7860615)

  • 1. Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma.
    Jafari M; Papp T; Kirchner S; Diener U; Henschler D; Burg G; Schiffmann D
    J Cancer Res Clin Oncol; 1995; 121(1):23-30. PubMed ID: 7860615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi.
    Carr J; Mackie RM
    Br J Dermatol; 1994 Jul; 131(1):72-7. PubMed ID: 8043423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions.
    Papp T; Jafari M; Schiffmann D
    J Cancer Res Clin Oncol; 1996; 122(9):541-8. PubMed ID: 8781568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of evidence of Ki-ras codon 12 mutations in melanocytic lesions.
    Albino AP; Nanus DM; Davis ML; McNutt NS
    J Cutan Pathol; 1991 Aug; 18(4):273-8. PubMed ID: 1939786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype.
    Albino AP; Nanus DM; Mentle IR; Cordon-Cardo C; McNutt NS; Bressler J; Andreeff M
    Oncogene; 1989 Nov; 4(11):1363-74. PubMed ID: 2682463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of UV-radiation in the development of conjunctival malignant melanoma.
    El-Shabrawi Y; Radner H; Muellner K; Langmann G; Hoefler G
    Acta Ophthalmol Scand; 1999 Feb; 77(1):31-2. PubMed ID: 10071144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of ras gene mutations in UV-induced malignant melanomas correlates with a dermal origin of melanocytes in Monodelphis domestica.
    Chan J; Robinson ES; Yeh IT; McCarrey JR
    Cancer Lett; 2002 Oct; 184(1):73-80. PubMed ID: 12104050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma.
    Wagner SN; Ockenfels HM; Wagner C; Höfler H; Goos M
    J Invest Dermatol; 1995 May; 104(5):868-71. PubMed ID: 7738369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.
    van Elsas A; Zerp SF; van der Flier S; Krüse KM; Aarnoudse C; Hayward NK; Ruiter DJ; Schrier PI
    Am J Pathol; 1996 Sep; 149(3):883-93. PubMed ID: 8780392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations.
    Eskandarpour M; Hashemi J; Kanter L; Ringborg U; Platz A; Hansson J
    J Natl Cancer Inst; 2003 Jun; 95(11):790-8. PubMed ID: 12783933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
    van Dijk MC; Bernsen MR; Ruiter DJ
    Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF and NRAS mutations in melanoma and melanocytic nevi.
    Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
    Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin.
    Jiveskog S; Ragnarsson-Olding B; Platz A; Ringborg U
    J Invest Dermatol; 1998 Nov; 111(5):757-61. PubMed ID: 9804334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.
    Soparker CN; O'Brien JM; Albert DM
    Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2203-9. PubMed ID: 8505202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis.
    Demunter A; Ahmadian MR; Libbrecht L; Stas M; Baens M; Scheffzek K; Degreef H; De Wolf-Peeters C; van Den Oord JJ
    Cancer Res; 2001 Jun; 61(12):4916-22. PubMed ID: 11406571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma.
    Demunter A; Stas M; Degreef H; De Wolf-Peeters C; van den Oord JJ
    J Invest Dermatol; 2001 Dec; 117(6):1483-9. PubMed ID: 11886512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras mutations in human melanoma: a marker of malignant progression.
    Ball NJ; Yohn JJ; Morelli JG; Norris DA; Golitz LE; Hoeffler JP
    J Invest Dermatol; 1994 Mar; 102(3):285-90. PubMed ID: 8120410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraviolet-B-light-induced mutagenesis of C-H-ras codons 11 and 12 in human skin fibroblasts.
    Amstad PA; Cerutti PA
    Int J Cancer; 1995 Sep; 63(1):136-9. PubMed ID: 7558442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
    Kumar R; Angelini S; Hemminki K
    Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.